Michael E. Thase

15.7k total citations · 5 hit papers
101 papers, 11.0k citations indexed

About

Michael E. Thase is a scholar working on Pharmacology, Psychiatry and Mental health and Experimental and Cognitive Psychology. According to data from OpenAlex, Michael E. Thase has authored 101 papers receiving a total of 11.0k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Pharmacology, 42 papers in Psychiatry and Mental health and 28 papers in Experimental and Cognitive Psychology. Recurrent topics in Michael E. Thase's work include Treatment of Major Depression (70 papers), Schizophrenia research and treatment (27 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (18 papers). Michael E. Thase is often cited by papers focused on Treatment of Major Depression (70 papers), Schizophrenia research and treatment (27 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (18 papers). Michael E. Thase collaborates with scholars based in United States, Germany and Singapore. Michael E. Thase's co-authors include Madhukar H. Trivedi, Maurizio Fava, A. John Rush, Stephen R. Wisniewski, Andrew A. Nierenberg, Jerrold F. Rosenbaum, Diane Warden, James F. Luther, Jonathan W. Stewart and David J. Kupfer and has published in prestigious journals such as New England Journal of Medicine, American Journal of Psychiatry and Journal of Consulting and Clinical Psychology.

In The Last Decade

Michael E. Thase

88 papers receiving 10.5k citations

Hit Papers

Acute and Longer-Term Outcomes in Depressed Outpatients R... 2006 2026 2012 2019 2006 2010 2006 2006 2006 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report
    2006 3.8k citations A. John Rush, Madhukar H. Trivedi et al. American Journal of Psychiatry profile →
  2. PRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder
    2010 995 citations Jerrold F. Rosenbaum, Michael E. Thase et al. profile →
  3. Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression
    2006 759 citations A. John Rush, Madhukar H. Trivedi et al. New England Journal of Medicine profile →
  4. Medication Augmentation after the Failure of SSRIs for Depression
    2006 742 citations Madhukar H. Trivedi, Maurizio Fava et al. New England Journal of Medicine profile →
  5. Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder
    2006 535 citations A. John Rush, Harold A. Sackeïm et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael E. Thase United States 34 6.4k 3.8k 3.0k 2.6k 1.7k 101 11.0k
James F. Luther United States 41 5.3k 0.8× 3.4k 0.9× 2.9k 1.0× 2.4k 0.9× 1.4k 0.8× 116 11.4k
Melanie M. Biggs United States 37 6.1k 1.0× 4.1k 1.1× 3.4k 1.1× 2.2k 0.9× 1.5k 0.9× 63 10.7k
Robert H. Howland United States 46 4.6k 0.7× 2.7k 0.7× 2.6k 0.9× 1.9k 0.7× 1.6k 1.0× 221 10.1k
George I. Papakostas United States 56 4.8k 0.8× 3.4k 0.9× 2.4k 0.8× 2.9k 1.1× 1.5k 0.9× 243 10.6k
Jonathan W. Stewart United States 53 6.5k 1.0× 4.1k 1.1× 3.9k 1.3× 2.6k 1.0× 3.2k 1.9× 178 12.9k
Kathy Shores‐Wilson United States 31 4.9k 0.8× 2.9k 0.8× 2.7k 0.9× 1.9k 0.8× 1.0k 0.6× 43 8.5k
Diane Warden United States 42 8.7k 1.4× 4.4k 1.2× 4.4k 1.5× 4.0k 1.5× 2.3k 1.4× 80 14.9k
Jonathan E. Alpert United States 66 4.5k 0.7× 3.7k 1.0× 3.3k 1.1× 2.0k 0.8× 1.8k 1.1× 233 12.7k
Richard C. Shelton United States 57 4.4k 0.7× 3.5k 0.9× 3.6k 1.2× 2.7k 1.1× 1.8k 1.1× 244 13.5k
Arun Ravindran Canada 53 3.3k 0.5× 3.8k 1.0× 1.9k 0.6× 1.8k 0.7× 953 0.6× 192 10.8k

Countries citing papers authored by Michael E. Thase

Since Specialization
Citations

This map shows the geographic impact of Michael E. Thase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Thase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Thase more than expected).

Fields of papers citing papers by Michael E. Thase

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Thase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Thase. The network helps show where Michael E. Thase may publish in the future.

Co-authorship network of co-authors of Michael E. Thase

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Thase. A scholar is included among the top collaborators of Michael E. Thase based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Thase. Michael E. Thase is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fleurence, Rachael, Rebecca Williamson, Yonghua Jing, et al.. (2025). A Systematic Review of Augmentation Strategies for Patients with Major Depressive Disorder. Psychopharmacology Bulletin. 42(3). 57–91. 2 indexed citations
2.
Thase, Michael E., et al.. (2024). Safety and tolerability of cariprazine for the adjunctive treatment of major depressive disorder: a pooled analysis of phase 2b/phase 3 clinical trials. International Clinical Psychopharmacology. 40(1). 27–36. 3 indexed citations
3.
Vittengl, Jeffrey R., Lee Anna Clark, Michael E. Thase, & Robin B. Jarrett. (2021). Stability and Change in Relations Between Personality Traits and the Interpersonal Problems Circumplex During Cognitive Therapy for Recurrent Depression. Assessment. 29(6). 1158–1171. 2 indexed citations
4.
Vittengl, Jeffrey R., Lee Anna Clark, Michael E. Thase, & Robin B. Jarrett. (2018). Partner criticism during acute-phase cognitive therapy for recurrent major depressive disorder. Behaviour Research and Therapy. 113. 48–56. 2 indexed citations
5.
Keyloun, Katelyn R., Ryan N. Hansen, Zsolt Hepp, et al.. (2017). Adherence and Persistence Across Antidepressant Therapeutic Classes: A Retrospective Claims Analysis Among Insured US Patients with Major Depressive Disorder (MDD). CNS Drugs. 31(5). 421–432. 65 indexed citations
6.
Dodd, Seetal, Philip B. Mitchell, Michael Bauer, et al.. (2017). Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement. The World Journal of Biological Psychiatry. 19(5). 330–348. 39 indexed citations
7.
Thase, Michael E., Richard H. Weisler, J. Sloan Manning, & Madhukar H. Trivedi. (2017). Utilizing the <em>DSM-5</em> Anxious Distress Specifier to Develop Treatment Strategies for Patients With Major Depressive Disorder. The Journal of Clinical Psychiatry. 78(9). 1351–1362. 11 indexed citations
8.
Thase, Michael E., Natalya Danchenko, Mélanie Brignone, et al.. (2017). Comparative evaluation of vortioxetine as a switch therapy in patients with major depressive disorder. European Neuropsychopharmacology. 27(8). 773–781. 21 indexed citations
9.
Trivedi, Madhukar H. & Michael E. Thase. (2015). Algorithms in Clinical Psychiatry: A Stepped Approach Toward the Path to Recovery. Psychopharmacology Bulletin. 36(Suppl. 2). 142–149.
10.
Kornstein, Susan G., Roger S. McIntyre, Michael E. Thase, & Matthieu Boucher. (2014). Desvenlafaxine for the treatment of major depressive disorder. Expert Opinion on Pharmacotherapy. 15(10). 1449–1463. 13 indexed citations
11.
Denton, Wayne H., Thomas Carmody, A. John Rush, et al.. (2009). Dyadic discord at baseline is associated with lack of remission in the acute treatment of chronic depression. Psychological Medicine. 40(3). 415–424. 33 indexed citations
12.
Trivedi, Madhukar H., Michael E. Thase, Olawale Osuntokun, et al.. (2009). An Integrated Analysis of Olanzapine/Fluoxetine Combination in Clinical Trials of Treatment-Resistant Depression. The Journal of Clinical Psychiatry. 70(3). 387–396. 50 indexed citations
13.
Zisook, Sidney, Madhukar H. Trivedi, Diane Warden, et al.. (2009). Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: An examination of citalopram in the STAR⁎D study. Journal of Affective Disorders. 117(1-2). 63–73. 82 indexed citations
14.
Bryan, Charlene, Thomas J. Songer, Maria M. Brooks, et al.. (2009). The impact of diabetes on depression treatment outcomes. General Hospital Psychiatry. 32(1). 33–41. 24 indexed citations
15.
Papakostas, George I., Maurizio Fava, & Michael E. Thase. (2007). Treatment of SSRI-Resistant Depression: A Meta-Analysis Comparing Within- Versus Across-Class Switches. Biological Psychiatry. 63(7). 699–704. 185 indexed citations
16.
Rush, A. John, Madhukar H. Trivedi, Stephen R. Wisniewski, et al.. (2006). Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression. New England Journal of Medicine. 354(12). 1231–1242. 759 indexed citations breakdown →
17.
Rush, A. John, Madhukar H. Trivedi, Stephen R. Wisniewski, et al.. (2006). Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report. American Journal of Psychiatry. 163(11). 1905–1917. 3823 indexed citations breakdown →
18.
McGrath, Patrick J., Jonathan W. Stewart, Maurizio Fava, et al.. (2006). Tranylcypromine Versus Venlafaxine Plus Mirtazapine Following Three Failed Antidepressant Medication Trials for Depression: A STAR*D Report. American Journal of Psychiatry. 163(9). 1531–1541. 231 indexed citations
19.
Fava, Maurizio, A. John Rush, Madhukar H. Trivedi, et al.. (2003). Background and rationale for the Sequenced Treatment Alternatives to Relieve Depression (STAR∗D) study. Psychiatric Clinics of North America. 26(2). 457–494. 431 indexed citations
20.
Thase, Michael E.. (2001). Scientific Foundations of Cognitive Theory and Therapy of Depression. PubMed Central. 10(4). 286–287. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James F. Luther Breakdown of academic impact, for papers by Melanie M. Biggs Breakdown of academic impact, for papers by Robert H. Howland Breakdown of academic impact, for papers by George I. Papakostas Breakdown of academic impact, for papers by Jonathan W. Stewart Breakdown of academic impact, for papers by Kathy Shores‐Wilson Breakdown of academic impact, for papers by Diane Warden Breakdown of academic impact, for papers by Jonathan E. Alpert Breakdown of academic impact, for papers by Richard C. Shelton Breakdown of academic impact, for papers by Arun Ravindran
Rankless by CCL
2026